IFI-C · Neomenthol

Specimen SS-F-CLB-592 // COOL BURN · IFI-C

Neomenthol IV-IV-B

Mentha × piperita

Peppermint

Tier IVNeomenthol

Target Trait

2.9×

fold-change

neomenthol accumulation fold-change

Technical Specifications

SKU

SS-F-CLB-592

Genomic Edits

6

GC Content

46.2%

Construct Length

3,668 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro T7/SP6 cell-free

Host Strain

Cell-free

Receptor Target

TRPM8

IFI Score

290

Pathway Edits

  • MNR-alt (menthone reductase alternative stereoisomer variant) precision editing for neomenthol specificity
  • PS (pulegone synthase) upregulation for precursor substrate maintenance
  • MNPQ-alt (menthone 9-reductase alternative variant) stereoselective co-upregulation
  • L-menthol oxidase suppression cassette to prevent competing menthol accumulation

Key Interventions

Neomenthol stereoisomeric TRPM8 variant overproduction via MNR-alt/MNPQ-alt engineeringStereoselective menthone reduction bias toward neomenthol over L-menthol via variant integrationTRPM8 receptor activation with distinct milder-cooling neomenthol sensory profile

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
290
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Industrial neomenthol production, next-generation mild-cooling ingredient supply chains, clinical stereoisomeric TRPM8 pharmacology research, and novel soft-cooling platform development.

License

$4049 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?